Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Comparative effectiveness of teriflunomide vs dimethyl fumarate in multiple sclerosis.

Laplaud DA, Casey R, Barbin L, Debouverie M, De Sèze J, Brassat D, Wiertlewski S, Brochet B, Pelletier J, Vermersch P, Edan G, Lebrun-Frenay C, Clavelou P, Thouvenot E, Camdessanché JP, Tourbah A, Stankoff B, Al Khedr A, Cabre P, Lubetzki C, Papeix C, Berger E, Heinzlef O, Debroucker T, Moreau T, Gout O, Bourre B, Wahab A, Labauge P, Magy L, Defer G, Guennoc AM, Maubeuge N, Labeyrie C, Patry I, Nifle C, Casez O, Michel L, Rollot F, Leray E, Vukusic S, Foucher Y; SFSEP and OFSEP groups.

Neurology. 2019 Aug 13;93(7):e635-e646. doi: 10.1212/WNL.0000000000007938. Epub 2019 Jul 12.

PMID:
31300547
2.

Early radiological features of severe longitudinally extensive transverse myelitis over time.

Cattan S, Papeix C, Grabli D, Casez O, Shor N, Bustuchina Vlaicu M, Vicart S, Louapre C, Maillart E.

J Neurol Sci. 2019 May 15;400:7-9. doi: 10.1016/j.jns.2019.01.043. Epub 2019 Feb 4. No abstract available.

PMID:
30878638
3.

A proliferation-inducing ligand-mediated anti-inflammatory response of astrocytes in multiple sclerosis.

Baert L, Benkhoucha M, Popa N, Ahmed MC, Manfroi B, Boutonnat J, Sturm N, Raguenez G, Tessier M, Casez O, Marignier R, Ahmadi M, Broisat A, Ghezzi C, Rivat C, Sonrier C, Hahne M, Baeten D, Vives RR, Lortat-Jacob H, Marche PN, Schneider P, Lassmann HP, Boucraut J, Lalive PH, Huard B.

Ann Neurol. 2019 Mar;85(3):406-420. doi: 10.1002/ana.25415. Epub 2019 Feb 4.

PMID:
30635946
4.

Metacognition and self-awareness in Multiple Sclerosis.

Mazancieux A, Souchay C, Casez O, Moulin CJA.

Cortex. 2019 Feb;111:238-255. doi: 10.1016/j.cortex.2018.11.012. Epub 2018 Nov 19. Review.

PMID:
30530267
5.

The role of APRIL - A proliferation inducing ligand - In autoimmune diseases and expectations from its targeting.

Baert L, Manfroi B, Casez O, Sturm N, Huard B.

J Autoimmun. 2018 Dec;95:179-190. doi: 10.1016/j.jaut.2018.10.016. Epub 2018 Oct 30. Review.

PMID:
30385081
6.

Treating asymptomatic bacteriuria before immunosuppressive therapy during multiple sclerosis: Should we do it?

Rouzaud C, Hautecoeur P, Donze C, Heinzlef O, Dinh A; Club Francophone de la Sclérose en Plaque, Creange A, Abdullatif A, Audouin B, Tourbah A, Berger E, Bourre B, Brochet B, Mekies C, Cabre P, Papeix C, Casez O, Brassat D, Defer G, Derache N, De Seze J, Dive D, LePage E, Fromont A, Gouider R, Edan G, Pelletier J, Grimaud J, Guennoc AM, Camdessanché JP, Kwiatkowski A, Laplaud D, Lebrun C, Debouverie M, Coustans M, Gout O, La Rochelle OA, Heinzlef O, Ouallet JC, Cavelou P, Hautecoeur P, Labauge P, Vermersch P, Wiertlewski S, Vukusic S, Marignier R, Schluep M, Seeldrayers P, Slassi I, Stankoff B, Thaite F, Moreau T, Thouvenot E, Zephir H, Ciron J, Collongues N, Kerschen P, Cohen M, Gueguen A, Mathey G, Carra C, Bernady P, Faucheux JM, Planque E, Donze C, Ruet A, Mouzawakh C, Pittion S.

Mult Scler Relat Disord. 2017 Nov;18:161-163. doi: 10.1016/j.msard.2017.08.009. Epub 2017 Aug 24. No abstract available.

PMID:
29141801
7.

Biotin in multiple sclerosis and false biological hyperthyroidism: Mind the interference.

Willeman T, Casez O, Faure P.

Rev Neurol (Paris). 2017 Mar;173(3):173-174. doi: 10.1016/j.neurol.2017.02.009. Epub 2017 Mar 14. No abstract available.

PMID:
28302321
8.

Evaluation of biotin interference on immunoassays: new data for troponin I, digoxin, NT-Pro-BNP, and progesterone.

Willeman T, Casez O, Faure P, Gauchez AS.

Clin Chem Lab Med. 2017 Aug 28;55(10):e226-e229. doi: 10.1515/cclm-2016-0980. No abstract available.

PMID:
28222017
9.

[Lower urinary tract dysfunction in normal pressure hydrocephalus: Review of the literature].

Bey E, Nicot B, Casez O, Le Normand L.

Prog Urol. 2016 Dec;26(17):1191-1199. doi: 10.1016/j.purol.2016.10.004. Epub 2016 Nov 2. Review. French.

PMID:
27816462
10.

CD62L test at 2 years of natalizumab predicts progressive multifocal leukoencephalopathy.

Pignolet B, Schwab N, Schneider-Hohendorf T, Bucciarelli F, Biotti D, Averseng-Peaureaux D, Outteryck O, Ongagna JC, de Sèze J, Brochet B, Ouallet JC, Debouverie M, Pittion S, Defer G, Derache N, Hautecoeur P, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Berger E, Pelletier J, Rico A, Zéphir H, Laplaud D, Wiertlewski S, Camu W, Thouvenot E, Casez O, Moreau T, Fromont A, Vukusic S, Papeix C, Vermersch P, Comabella M, Lebrun-Frenay C, Wiendl H, Brassat D; BIONAT, SFSEP, and BEST-MS networks.

Neurology. 2016 Dec 6;87(23):2491-2494. Epub 2016 Nov 4. No abstract available.

PMID:
27815407
11.

Guillain-Barré syndrome and cytomegalovirus infection during pregnancy.

Lupo J, Germi R, Jean D, Baccard-Longère M, Casez O, Besson G, Rougé A, Boutonnat J, Schwebel C, Hoffmann P, Morand P.

J Clin Virol. 2016 Jun;79:74-76. doi: 10.1016/j.jcv.2016.04.010. Epub 2016 Apr 14.

PMID:
27105316
12.

Intérêt d'un auto-questionnaire simple pour le dépistage des troubles sphinctériens dans la sclérose en plaque (SEP).

Thuillier C, Overs C, Descotes J, Borgel F, Casez O, Fiard G, Chodez M.

Prog Urol. 2014 Nov;24(13):843. doi: 10.1016/j.purol.2014.08.133. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461659
13.

Chitinase 3-like proteins as diagnostic and prognostic biomarkers of multiple sclerosis.

Hinsinger G, Galéotti N, Nabholz N, Urbach S, Rigau V, Demattei C, Lehmann S, Camu W, Labauge P, Castelnovo G, Brassat D, Loussouarn D, Salou M, Laplaud D, Casez O, Bockaert J, Marin P, Thouvenot E.

Mult Scler. 2015 Sep;21(10):1251-61. doi: 10.1177/1352458514561906. Epub 2015 Feb 19.

PMID:
25698171
14.

Severe acute neurological symptoms related to proton pump inhibitors induced hypomagnesemia responsible for profound hypoparathyroidism with hypocalcemia.

Deroux A, Khouri C, Chabre O, Bouillet L, Casez O.

Clin Res Hepatol Gastroenterol. 2014 Oct;38(5):e103-5. doi: 10.1016/j.clinre.2014.03.005. Epub 2014 Apr 13. No abstract available.

PMID:
24736034
15.

Switching from natalizumab to fingolimod in multiple sclerosis: a French prospective study.

Cohen M, Maillart E, Tourbah A, De Sèze J, Vukusic S, Brassat D, Anne O, Wiertlewski S, Camu W, Courtois S, Ruet A, Debouverie M, Le Page E, Casez O, Heinzlef O, Stankoff B, Bourre B, Castelnovo G, Rico A, Berger E, Camdessanche JP, Defer G, Clavelou P, Al Khedr A, Zephir H, Fromont A, Papeix C, Brochet B, Pelletier J, Lebrun C; Club Francophone de la Sclérose en Plaques Investigators.

JAMA Neurol. 2014 Apr;71(4):436-41. doi: 10.1001/jamaneurol.2013.6240.

PMID:
24566807
16.

A prospective observational post-marketing study of natalizumab-treated multiple sclerosis patients: clinical, radiological and biological features and adverse events. The BIONAT cohort.

Outteryck O, Ongagna JC, Brochet B, Rumbach L, Lebrun-Frenay C, Debouverie M, Zéphir H, Ouallet JC, Berger E, Cohen M, Pittion S, Laplaud D, Wiertlewski S, Cabre P, Pelletier J, Rico A, Defer G, Derache N, Camu W, Thouvenot E, Moreau T, Fromont A, Tourbah A, Labauge P, Castelnovo G, Clavelou P, Casez O, Hautecoeur P, Papeix C, Lubetzki C, Fontaine B, Couturier N, Bohossian N, Clanet M, Vermersch P, de Sèze J, Brassat D; BIONAT Network,; CFSEP.

Eur J Neurol. 2014;21(1):40-8. doi: 10.1111/ene.12204. Epub 2013 Jun 12.

PMID:
23895407
17.

Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter study.

Collongues N, Casez O, Lacour A, Tranchant C, Vermersch P, de Seze J, Lebrun C.

Muscle Nerve. 2012 Nov;46(5):687-91. doi: 10.1002/mus.23412. Epub 2012 Aug 31.

PMID:
22941747
18.

Hallucinations treated with rivastigmine in Creutzfeldt-Jakob disease.

Chapuis C, Casez O, Lagrange E, Bedouch P, Besson G.

Fundam Clin Pharmacol. 2012 Apr;26(2):212-4. doi: 10.1111/j.1472-8206.2011.00959.x. Epub 2011 Jun 1.

PMID:
21631588
19.

[Idiopathic transient global amnesia].

Véran O, Barré M, Casez O, Vercueil L.

Psychol Neuropsychiatr Vieil. 2008 Dec;6(4):265-75. doi: 10.1684/pnv.2008.0145. Review. French.

20.

[Abnormal movements of psychogenic origin: usefulness of the readiness potential].

Casez O, Vercueil L.

Rev Neurol (Paris). 2006 Jun;162(6-7):770-2. French. No abstract available.

PMID:
16840990
21.

Migraine and somnambulism.

Casez O, Dananchet Y, Besson G.

Neurology. 2005 Oct 25;65(8):1334-5. No abstract available.

PMID:
16247080
22.

Quinacrine-induced cytolytic hepatitis in sporadic Creutzfeldt-Jakob disease.

Scoazec JY, Krolak-Salmon P, Casez O, Besson G, Thobois S, Kopp N, Perret-Liaudet A, Streichenberger N.

Ann Neurol. 2003 Apr;53(4):546-7. No abstract available.

PMID:
12666126

Supplemental Content

Support Center